ABSTRACT
Afar, D.E., V. Bhaskar, E. Ibsen, D. Breinberg, S.M. Henshall, J.G. Kench, M. Drobnjak, R. Powers, M. Wong, F. Evangelista, C. O’Hara, D. Powers, R.B. DuBridge, I. Caras, R. Winter, T. Anderson, N. Solvason, P.D. Stricker, C. Cordon-Cardo, H.I. Scher, J.J. Grygiel, R.L. Sutherland, R. Murray, V. Ramakrishnan, and D.A. Law. 2004. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Mol. Cancer. Th er. 3: 921-932.
